![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1559, 2006-01, pp. : 18-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Levosalbutamol in the treatment of asthma
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Levosalbutamol yields "economic advantages" in asthma, COPD
Inpharma, Vol. 1, Iss. 1377, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Nebulised budesonide as effective as oral prednisolone in COPD
Inpharma, Vol. 1, Iss. 1336, 2002-01 ,pp. :